Gsa Capital Partners LLP Pacific Biosciences Of California, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$1.36 - $3.65 $810,388 - $2.17 Million	595,874 New	595,874 $816,000
Q2 2020 Aug 11, 2020	SELL	$2.65 - $4.03 $350,001 - $532,266	-132,076 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$2.36 - $5.26 $311,699 - $694,719	132,076 New	132,076 $404,000
Q2 2019 Aug 06, 2019	SELL	$5.92 - $7.41 $292,465 - $366,076	-49,403 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.8 - $7.4 $335,940 - $365,582	49,403 New	49,403 $357,000

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $472M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.